Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice
- 1 November 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 131 (2-3) , 289-292
- https://doi.org/10.1016/0014-2999(86)90585-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in miceEuropean Journal of Pharmacology, 1986
- VII. Determination of catecholamines in tissue and body fluids using microbore HPLC with amperometric detectionLife Sciences, 1985
- The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatmentNeuroscience Letters, 1985
- Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proceedings of the National Academy of Sciences, 1985
- Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1985
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984
- Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.Proceedings of the National Academy of Sciences, 1982